Creative Biolabs Accomplished the Journey for the 20th European Drug Discovery Event

 Breaking News
  • No posts were found

Creative Biolabs Accomplished the Journey for the 20th European Drug Discovery Event

Based on the excellent platform of the 20th European Drug Discovery Innovation and Outsourcing Programme, Creative Biolabs has accomplished its biotech journey in Europe.

New York, USA – September 20, 2023 – On September 13, 2023, the 20th European Drug Discovery Innovation and Outsourcing Programme concluded successfully. Creative Biolabs, an exhibitor at this event, showcased its latest updated solutions and technologies targeting new drug discovery. Discussions with attending researchers and scientists were fruitful, as evidenced by the high praise received from attendees.

“This event was held with total success, and we gained many excellent views and insights into drug discovery,” noted a representative scientist at Creative Biolabs. “At this event, we met many prospective clients working in drug discovery who are fully interested in our innovative solutions that expedite their research projects.”

Creative Biolabs showcased to attendees its newly released humanized mouse models. Humanized mouse models contribute to ensuring considerable progress in research in oncology, human infectious diseases, allergies, regenerative medicine, graft-versus-host disease, and immunity.

“We have the confidence to provide various types of humanized mouse models as well as custom mouse models, based on our extensive experience in this field,” added an expert.

Also, the representative of Creative Biolabs detailed the featured advantages of animal PK/PD models and toxicity test services to researchers who came to their booth.

“We focus not only on diverse animal PK/PD models but also on custom animal models to support researchers in their therapeutics discovery,” commented an attending expert. “We also showcased to attendees a suite of toxicity test services that are utilized for the assessment of drug safety profiles, widely ranging from cytotoxicity, gene toxicity, cardiotoxicity, and hepatotoxicity to ophthalmic toxicity.”

The 20th European Drug Discovery Event witnessed dependable and professional knowledge and ability in the biotechnology development of Creative Biolabs, showcasing the firm’s innovative strides in new drug discovery and development. The event, meanwhile, also enhanced Creative Biolabs’ strive to incessantly offer profound contributions to the progression of global biological and therapeutic research and development.

To learn more information about drug discovery services and event arrangements, please visit https://www.creative-biolabs.com/drug-discovery/therapeutics.

About Creative Biolabs

As a world-leading biotechnology company, Creative Biolabs specializes in providing custom solutions and services to support researchers in their whole drug discovery pipelines based on its extensive scientific resources and advanced technology platforms. Creative Biolabs will exhibit at Bio Japan 2023 in the upcoming October, with the hope of discussing new insights with attending scientists about biotechnology development.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/drug-discovery/therapeutics

Categories